Welcome: Guest | Site Use Options | Register | Login |

FOB Synthesis

 Synopsis: Business Condition
Year Founded N/A
Employment N/A
Sector N/A
Industry N/A
FOB Synthesis
     Last modified on: 00/00/00

Achillion gets carbapenem compounds from FOB Synthesis
Deal Date: Apr-01-2008 / Deal # 200820214
Executive Summary

FOB Synthesis (uses synthetic organic and medicinal chemistry for drug discovery ) licensed Achillion Pharmaceuticals (infectious disease therapeutics) exclusive worldwide rights to develop and commercialize carbapenem compounds for bacterial infections.


SBIR firms in the news

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920